Form D · Pharmaceuticals

AltaThera Pharmaceuticals, LLC

Chicago, IL · CIK 0001604121

Offering snapshot reported Aug 22, 2019 · SEC filing

Reported sold
$1.53M
Offering amount: $4M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 22, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$766K$1.53MMay 6, 2019: $150,000.00May 6, 2019Aug 22, 2019: $1,531,430.00Aug 22, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$150,000 → $1,531,430

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 22, 2019Amendment$1,531,430$1,381,430vs May 6, 20192SEC filing
May 6, 2019Initial$150,000No comparison2SEC filing
Dec 23, 2016Initial$3,350,000No comparison12SEC filing
Nov 3, 2016Initial$225,000No comparison4SEC filing
Jul 31, 2015Initial$1,000,000No comparison1SEC filing
Feb 3, 2015Initial$1,000,000No comparison1SEC filing
Jan 30, 2015Initial$500,000No comparison1SEC filing

Offering details

Securities
Debt, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$29.6K (estimated)
Finders' fees
$0
Form D file number
021-338880

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
M Barc Investment Group Inc41082Silverwood Partners · CRD 115589

Source: Form D, filed Aug 22, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Merrill Barden Executive
Merrill Bardin Executive
Jodi Devlin Executive
John Flavin Director
Brandon Kashfian Executive
Stephen Osullivan Executive
Stephen O'sullivan Director, Executive
Stephen O?Sullivan Director, Executive
Mahlaqa Patel Executive
John Somberg Executive
Jay Welsh Executive
Rick White Executive
James Wittenberg Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
200 South Wacker Drive Suite 3100
Chicago, IL, 60606